LON:MCGN - Microgen Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 367.50
▲ +0.5 (0.14%)
1 month | 3 months | 12 months
Get New Microgen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MCGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MCGN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Microgen in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 367.50.
N/A
The current consensus among 0 investment analysts is to n/a stock in Microgen. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
7/6/2017InvestecReiterated RatingBuyGBX 400
i
(Data available from 4/14/2016 forward)
Microgen logo
Microgen plc, together with its subsidiaries, develops, implements, and supports business critical software and related services in the United Kingdom and internationally. It operates through two segments, Aptitude Software and Microgen Financial Systems. The Aptitude Software segment provides a suite of specialized finance management software applications for banking, healthcare, insurance, and telecommunications customers. Its applications include Aptitude Insurance Calculation Engine that focuses on insurance contracts; Aptitude Lease Accounting Engine, which addresses leasing standards; Aptitude Revenue Recognition Engine for revenue recognition requirements; Aptitude RevStream, a cloud-enabled revenue management software; Aptitude Accounting Hub that transforms financial, management, and statutory accounting; and Aptitude Allocation Engine that offers interfaces to set-up and apply rules to allocate cost and revenue. This segment licenses its software; and provides software maintenance/support, software subscriptions for its cloud-based offerings; and implementation services. The Microgen Financial Systems segment offers Microgen 5Series, a wealth management software for both on-shore and off-shore markets; and Microgen Bacway, a suite of payments software products. It also provides maintenance, support, and development services on a range of software products and applications developed by third parties. Microgen plc was founded in 1974 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: GBX 367.50
365
367.50

50 Day Range

MA: GBX 367.50
367.50
367.50

52 Week Range

Now: GBX 367.50
332
482

Volume

26,257 shs

Average Volume

15,829 shs

Market Capitalization

£224.83 million

P/E Ratio

17.09

Dividend Yield

1.65%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Microgen?

The following sell-side analysts have issued research reports on Microgen in the last year:
View the latest analyst ratings for MCGN.

What is the current price target for Microgen?

0 Wall Street analysts have set twelve-month price targets for Microgen in the last year. has the lowest price target set, forecasting a price of £100,000 for Microgen in the next year.
View the latest price targets for MCGN.

What is the current consensus analyst rating for Microgen?

Microgen currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MCGN.

What other companies compete with Microgen?

How do I contact Microgen's investor relations team?

Microgen's physical mailing address is Old Change House 128 Queen Victoria Street, LONDON, EC4V 4BJ, United Kingdom. The company's listed phone number is +44-20-74968100. The official website for Microgen is www.microgen.com.